feisty
Appointing a director from a competing company is one of the most charged signals an ASX board can send. It doesn't happen often. When it does, the market notices, rivals notice, and sometimes regulators notice too. The press release will talk about "deep sector experience" and "strategic perspective." What it won't say is why that particular person, from that particular place, right now.
Why boards do it
The most straightforward reason is talent scarcity. In narrow industries, the pool of people with genuine operational depth is small. Mining services, specialty insurance, listed infrastructure: these sectors run on a few dozen people who have actually made the significant decisions. If the board needs someone who understands a specific asset class or regulatory environment at a working level, the candidates who meet that bar may all be sitting on competitor boards or in competitor executive teams.
The second reason is intelligence. Not industrial espionage, but the kind of knowledge that attaches to a person: how a competitor structures its risk function, what disciplines it prioritises, what the market looks like from the other side of a bidding table. A director can't legally bring confidential information with them. But judgement doesn't stay behind. Experience doesn't stay behind.
Third: signalling to the rival itself. A board that successfully recruits a senior figure from a competitor is telling the market something about relative attractiveness. It's a recruitment signal dressed as a governance appointment.
What the legal exposure looks like
The appointment immediately raises three legal questions, and boards that don't work through all three publicly are usually working through them privately.
The first is confidential information. Directors owe duties to the companies they serve. A person leaving a competitor board carries residual obligations to that former employer. The incoming board needs to know what those obligations are, how long they last, and whether the new director will need to recuse from specific discussions as a result. Recusal obligations that aren't spelled out in advance create the worst kind of problem: ones that surface during a live transaction.
The second is competition law. The Australian Competition and Consumer Commission has clear views on interlocking directorships between rivals. Section 50A of the Competition and Consumer Act prohibits a person from being a director of two competing corporations simultaneously where the effect is to substantially lessen competition. The operative word is "simultaneously." A director who has fully resigned from the competitor board before joining the new one is outside that prohibition. A director who hasn't is not.
The third is conflicts management. Even where no legal prohibition applies, the board's conflicts policy needs to address how the new director participates in decisions that directly affect the former employer. This isn't theoretical. If the company is considering an acquisition of the rival, or a tender that competes with the rival, or a regulatory submission that affects the rival's interests, the new director sits in an uncomfortable position. Boards that don't document how they'll manage this in advance end up managing it badly under pressure.
What the timing usually means
The appointment rarely arrives at a neutral moment. Boards don't add this kind of complexity unless they think they need what the person brings. Three timing patterns recur.
The first is pre-transaction. A board building toward an acquisition or a merger wants someone who understands the target's world from the inside. If the target is a direct competitor, recruiting a former competitor director in the 12 months before a bid is announced has a logic that retrospectively becomes obvious.
The second is post-disruption. When a competitive market shifts, through technology, regulation, or a new entrant, the instinct is to bring in someone who has already navigated the change from the front. The competitor who handled it best becomes a talent source. The director appointment is the board's acknowledgment that its own collective experience has a gap.
The third is defensive. If a rival has been publicly circling the company, adding a director who knows how that rival operates is a way of building institutional knowledge about the threat without announcing that the threat is being taken seriously.
What it signals about the board's confidence in management
This is the reading the market makes last, but it's often the most accurate one. A board that trusts its management team to understand the competitive environment doesn't usually feel compelled to put a competitor director in the room. When the appointment happens without an obvious transaction driver, it's worth asking whether the board thinks management has a blind spot about how the competition actually works.
That question sits uncomfortably close to the dynamics described in analyses of when the board appoints a director with no industry experience: in both cases, the board is filling a gap it perceives at the table, and the act of filling it says something about where the board thinks the company is exposed.
The recusal problem in practice
Boards underestimate how often the new director will need to step out of the room. In a competitive market, almost every significant strategic discussion touches the rival. Pricing decisions touch it. Procurement decisions touch it. Responses to regulatory consultations touch it. If the director's recusal obligations are broad, the board has effectively added a member who can't participate in the work the board most needs to do.
The solution isn't to narrow the recusal obligations artificially. It's to be precise about them before the appointment is made. A competent conflicts framework, reviewed by external counsel and documented in the board charter, converts a potential problem into a managed one. Boards that skip this step tend to discover the gap when a contested decision needs to be made quickly.
How investors read the move
Institutional investors apply different frameworks depending on context. A former executive from a direct competitor, arriving shortly before a publicly rumoured transaction, reads as strategic. The same person, arriving with no visible catalyst, reads as a governance question: what does the board know that it hasn't told the market?
Proxy advisers focus on the independence question. A director who has recently been employed by, or sat on the board of, a rival is unlikely to be classified as independent under the ASX Corporate Governance Council's principles. That reduces the pool of independent directors available for committee work. If the board is already stretched on independence, the competitor appointment compounds the problem.
Sophisticated investors also watch what happens to the former employer after the appointment. If the former employer's competitive position deteriorates in the 18 months following the appointment, the new director will face questions about whether confidential knowledge played any role, even if it didn't. Perception management is part of the governance problem.
The questions a board should answer first
Before making the appointment, a well-governed board documents answers to four specific questions. What confidential information did this person have access to at the competitor, and when does the obligation to protect it expire? What decisions at this company will require recusal, and how often will those decisions arise? Does the appointment create any simultaneous directorship issue under competition law? And does adding this person reduce the board's independence profile in a way that creates a committee problem?
Boards that work through these questions in advance tend to make the appointment well. Those that treat them as formalities to tick off after the decision is made tend to find that the questions return in worse circumstances, usually during a transaction or a regulatory inquiry.
The competitor director appointment isn't inherently problematic. It's one of the more complex governance moves available, and complexity handled well is a signal of its own. As with when the board creates a special committee, the decision itself is less revealing than the care with which it's managed.